Lantern Pharma Inc. (LTRN) stock
LTRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.36−0.02 (-6.17%)
Close on Nov 17, 2026Market cap $4.67MP/E –Yield –
Lantern Pharma cash
Cash and short-term investments held at the end of each period.
Lantern Pharma's cash was $7.63M at Sep 30, 2026. For fiscal 2025 it was $10.12M, down 57.9% from the year before. The highest annual figure on record is $70.73M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.12M | -57.9% |
| FY2024 | Dec 31, 2024 | $24.01M | -41.9% |
| FY2023 | Dec 31, 2023 | $41.30M | -25.2% |
| FY2022 | Dec 31, 2022 | $55.20M | -22.0% |
| FY2021 | Dec 31, 2021 | $70.73M | +267.8% |
| FY2020 | Dec 31, 2020 | $19.23M | +1460.8% |
| FY2019 | Dec 31, 2019 | $1.23M | +176.8% |
| FY2018 | Dec 31, 2018 | $445.16K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.63M | -38.3% |
| Q2 FY2026 | Jun 30, 2026 | $7.36M | -53.7% |
| Q1 FY2026 | Mar 31, 2026 | $6.32M | -67.9% |
| Q4 FY2025 | Dec 31, 2025 | $10.12M | -57.9% |
| Q3 FY2025 | Sep 30, 2025 | $12.36M | -55.9% |
| Q2 FY2025 | Jun 30, 2025 | $15.90M | -52.2% |
| Q1 FY2025 | Mar 31, 2025 | $19.72M | -48.6% |
| Q4 FY2024 | Dec 31, 2024 | $24.01M | -41.9% |
| Q3 FY2024 | Sep 30, 2024 | $28.05M | -37.6% |
| Q2 FY2024 | Jun 30, 2024 | $33.26M | -30.6% |
| Q1 FY2024 | Mar 31, 2024 | $38.36M | -25.6% |
| Q4 FY2023 | Dec 31, 2023 | $41.30M | -25.2% |
| Q3 FY2023 | Sep 30, 2023 | $44.93M | -22.3% |
| Q2 FY2023 | Jun 30, 2023 | $47.95M | -22.8% |
| Q1 FY2023 | Mar 31, 2023 | $51.54M | -21.0% |
| Q4 FY2022 | Dec 31, 2022 | $55.20M | -22.0% |
| Q3 FY2022 | Sep 30, 2022 | $57.83M | -21.7% |
| Q2 FY2022 | Jun 30, 2022 | $62.15M | -21.9% |
| Q1 FY2022 | Mar 31, 2022 | $65.22M | -19.9% |
| Q4 FY2021 | Dec 31, 2021 | $70.73M | +267.8% |
| Q3 FY2021 | Sep 30, 2021 | $73.83M | +254.9% |
| Q2 FY2021 | Jun 30, 2021 | $79.59M | +234.4% |
| Q1 FY2021 | Mar 31, 2021 | $81.37M | +12730.0% |
| Q4 FY2020 | Dec 31, 2020 | $19.23M | +1460.8% |
| Q3 FY2020 | Sep 30, 2020 | $20.80M | +971.8% |
| Q2 FY2020 | Jun 30, 2020 | $23.80M | +1568.8% |
| Q1 FY2020 | Mar 31, 2020 | $634.25K | +42.5% |
| Q4 FY2019 | Dec 31, 2019 | $1.23M | – |
| Q3 FY2019 | Sep 30, 2019 | $1.94M | – |
| Q2 FY2019 | Jun 30, 2019 | $1.43M | – |
| Q4 FY2018 | Dec 31, 2018 | $445.16K | – |
See a number that looks wrong?